In the present study, to date the largest and most comprehensive study with extensive clinical annotation and samples ranging from precursors through primary to metastatic endometrial carcinoma lesions, we find that precursor lesions and well-differentiated primary tumors have the highest level of AR, with a gradual decrease in AR level with dedifferentiation. The gene discussed is AR; the disease is endometrial carcinoma.